化企赴港上市浪潮涌动

Group 1 - A number of Chinese chemical companies are pursuing listings in Hong Kong, driven by the Hong Kong Stock Exchange's optimized listing approval process for qualified A-share companies [1][2] - On May 20, CATL's H-shares were listed on the Hong Kong Stock Exchange, closing at HKD 306.2, a 16.43% increase from the issue price, raising over HKD 35.3 billion, marking the largest IPO globally this year [1] - The IPO set three records: the largest IPO project globally in 2023, the largest IPO in Hong Kong in the past four years, and the largest A-share company to list in Hong Kong [1] Group 2 - The Hong Kong Securities and Futures Commission and the Stock Exchange have been continuously optimizing the listing approval process since last year, facilitating A-share companies' applications [2] - The second listing in Hong Kong provides A-share companies with significant financing capabilities and helps expand their international business footprint [2] - A-share companies' secondary listings in Hong Kong represent "secondary financing," providing funds for further business development [3] Group 3 - The Hong Kong market is expected to become a financing hub and investment value high ground for the technology innovation industry amid the US-China tech rivalry and supportive domestic policies [3] - More leading A-share companies, including CATL and Baile Tianheng, are actively embracing the Hong Kong market to build an international capital platform [3] - The pricing model for H-shares is continuously optimized, benefiting more A-share companies seeking to list in Hong Kong, while attracting long-term international investors can enhance the company's equity structure and boost investor confidence [3]